அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் ஆண்டு சந்தித்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் ஆண்டு சந்தித்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் ஆண்டு சந்தித்தல் Today - Breaking & Trending Today

New England Journal of Medicine Publishes 12-Week Results from Study Evaluating Atogepant for the Preventive Treatment of Migraine

ABBVie today announced that the New England Journal of Medicine has published 12-week results from the Phase 3 ADVANCE trial evaluating atogepant for the preventive treatment of migraine in adults who meet criteria for episodic migraine. The study, which enrolled adult participants experiencing 4 to 14 migraine days per month, found that all active treatment arms of atogepant 10 mg, 30 mg, and 60 mg once-daily . ....

United States , City Of , United Kingdom , Peter Goadsby , University Of California Los Angeles , Virtual Migraine Trust International Symposium , American Academy Of Neurology Annual Meeting , Drug Administration , International Classification Of Headache Disorders , Exchange Commission , King College , Migraine Research Foundation , New England Journal , Michael Gold , Migraine Specific Quality , Life Questionnaire , Role Function Restrictive , Daily Activities , Physical Impairment , Los Angeles , Migraine Trust International Symposium , Clinical Trials Plenary Session , Neurology Annual , Role Function Preventive , Emotional Function , Activity Impairment ,

TG Therapeutics, inc (TGTX) Q2 2021 Earnings Call Transcript

Greetings. Welcome to TG Therapeutics Second Quarter 2021 Earnings Call and Business Update. [Operator Instructions]
At this time, I will now turn the conference over to Jenna Bosco, Senior Vice President of Corporate Communications. Jenna, you may now begin.
Jenna Bosco
Senior Vice President, Corporate Communications
Thank you. Welcome everyone and thanks for joining us this morning. I m Jenna Bosco and with me today to discuss the second quarter 2021 financial results and provide a business update are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer. Following our Safe Harbor statement, Mike will provide an overview of our recent corporate developments as well as an update on our current pivotal programs and remaining key goals for 2021. Adam will then provide an update on our commercialization efforts and Sean will provide a brief overview of our financial r ....

New York , United States , Chris Howerton Jefferies , Matt Kaplan , Josh Schimmer Evercore , Graig Suvannavejh , Mayank Mamtani , Michael Weiss , Paul Barr , Alethia Young , Alethia Young Cantor Fitzgerald , Michaels Weiss , Red White , Adam Waldman , Matt Kaplan Ladenburg Thalmann , Josh Schimmer , Chris Howerton , Sean Power , Mike Weiss , Jenna Bosco , Mayank Mamtanib Riley , Deric Joseph , Eric Joseph Jpmorgan , Graig Suvannavejh Goldman Sachs , European Academy Of Neurology Annual Meeting , Ladenburg Thalmann ,

Harmony Biosciences Holdings, Inc. (HRMY) Q1 2021 Earnings Call Transcript

Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Harmony Biosciences first-quarter 2021 financial update call. [Operator instructions] I would now like to hand the conference over to your host today, Lisa Caperelli, investor relations. Please go ahead.
Lisa Caperelli
Investor Relations
Thank you, operator. Good morning, everyone and thank you for joining us today as we review Harmony Biosciences first-quarter 2021 financial performance and provide business updates. Before we begin, I encourage everyone to go to the Investors section of the Harmony Biosciences website to find the press release and slides that accompany our presentation today, including a reconciliation of the GAAP to non-GAAP financial measures. At this stage of our company life cycle, we believe non-GAAP financial results better represent the underlying economics of our business. ....

United States , Jeffrey Dayno , Chris Howerton Jefferies , Chris Howerton , John Jacobs , Lisa Caperelli , Piper Sandler , Graig Suvannavejh , Sandip Kapadia , Jeff Dayno , Jeffrey Dierks , David Amsellem , David Amsellem Piper Sandler , Graig Suvannavejh Goldman Sachs , Jeff Dierks , American Academy Of Neurology Annual Meeting , York State Department Of Health , Goldman Sachs , Harmony Biosciences Holdings Inc , American Academy Neurology Annual Meeting , Harmony Biosciences Holdings , Harmony Biosciences , Chief Executive , Sleep Medicine , Epworth Sleepiness Scale , American Academy ,

Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Call Transcript

Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Avadel Pharmaceuticals plc (NASDAQ: AVDL)
Q1 2021 Earnings Call
Operator
Greetings, and welcome to the Avadel Pharmaceuticals First Quarter 2021 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Tom McHugh, Chief Financial Officer. Thank you. You may begin.SPONSORED:
10 stocks we like better than Avadel Pharmaceuticals plc
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , Oren Livnat , Matt Kaplan , David Sherman , Gregoryj Divis , Paul Matteis Stifel , Marc Goodman , Paul Matteis , Raymond Wu Ladenburg Thalmann , Piper Sandler , Tom Mchugh , Richard Kim , Jennifer Gudeman , Thomass Mchugh , Francois Brisebois , Greg Divis , Francois Brisebois Oppenheimer , David Amsellem , David Sherman Lifesci , Clinical Affairs , Motley Fool Avadel Pharmaceuticals , Ladenburg Thalmann , Avadel Pharmaceuticals , American Academy Of Neurology Annual Meeting , David Amsellem Piper Sandler Co Analyst , American Academy Of Neurology ,

Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript

Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)
Q1 2021 Earnings Call
Operator
Welcome to the Jazz Pharmaceuticals PLC First Quarter 2021 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Andrea Flynn, Head Investor Relations at Jazz Pharmaceuticals. Thank you. Please go ahead.SPONSORED:
10 stocks we like better than Jazz Pharmaceuticals
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Motley Fool Stock Advisor, has tripled the market. ....

United States , David Risinger , Brucec Cozadd , Gary Nachman , Jason Gerberry , Kim Sablich , Marc Goodman Leerink , Graig Suvannavejh , Balaji Prasad Barclays , Jessica Fye , Anne Borgman , Annabel Samimy , Balaji Prasad , Marc Goodman , David Steinberg , Dan Swisher , Bruce Cozadd , America Merrill Lynch , Annabel Samimy Stifel Nicolaus , Andrean Flynn , Andrea Flynn , Piper Sandler , Gregg Gilbert , Phil Jochelson , David Risinger Morgan Stanley , Esther Rajavelu ,